The U.S. IPO market's strong 2026 rebound, with 119 traditional deals priced through mid-September and robust aftermarket gains averaging over 8%, sets the backdrop for continued activity into year-end. Multiple offerings are slated to price imminently, including Holtec Nuclear's $825 million deal, Electra Therapeutics at a $325 million midpoint, and Orion180 Insurance around $320 million, alongside smaller filings like World Road. Equity market strength, elevated Nasdaq levels, and sustained investor demand for AI-adjacent and growth names have supported pricing within or above ranges, while a pipeline of larger candidates including potential debuts from Oura and other tech firms points to further listings before January 2027. Key near-term catalysts include September and October roadshows amid stable Treasury yields and constructive economic data.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-updateMistral AI raises €3 billion at €20 billion valuation, plans IPO after 2026
Mistral AI drops to 5%5%
Mistral AI closed a €3 billion funding round in mid-2026 at a €20 billion valuation, nearly doubling its previous valuation. The company confirmed IPO plans but indicated the listing would likely occur after 2026, focusing on scaling and strategic partnerships in the meantime.
































Mag-ingat sa mga external link.
Mag-ingat sa mga external link.
Mga Madalas na Tanong